In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc. (NYSE:PFE) has agreed to ...
Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac. The ...
Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its ...
Pfizer has agreed to pay up to $250mn to settle more than 10,000 US lawsuits over cancer risks associated with its now-discontinued heartburn drug Zantac, according to people familiar with the deal.
Pfizer (NYSE:PFE) will pay up to $250M to settle more than 10,000 U.S. lawsuits alleging that the company concealed cancer ...
Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.
opens new tab has agreed to settle more than 10,000 lawsuits ... to Zantac claims, the report said, adding that financial details of the deals were not immediately available. Pfizer did not ...
Pfizer shares were up 1.5% to $28.19 at 11:55 a.m. in New York. -Past lawsuits- Bloomberg News reported last month that Sanofi agreed to pay more than $100 million to resolve about 4,000 Zantac cases.
Pfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation.
Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with ...
Zantac. According to a Bloomberg report, Pfizer has agreed to settle over 10,000 lawsuits that accused the company of concealing the cancer risks associated with Zantac. This settlement marks the ...